STAMARIL®

BIOLOGICAL3 trials

Sponsors

Institute Of Tropical Medicine, Sanofi Pasteur, a Sanofi Company, Serum Institute of India Pvt. Ltd.

Conditions

Yellow FeverYellow fever

Phase 3

A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL® In Healthy Infants

Serum Institute of India Pvt. Ltd.Yellow Fever

Start: 2022-09-16End: 2024-01-30Target: 2216Updated: 2023-11-28

A randomized controlled trial to compare the immunogenicity and skin imprinting of intradermal, subcutaneous and intramuscular yellow fever vaccination

RecruitingCTIS2024-514154-73-00

Institute Of Tropical MedicineYellow fever

Start: 2025-01-02Target: 222Updated: 2025-07-24

Unknown Phase

Passive Enhanced Safety Surveillance of Stamaril® Vaccine in Korea

CompletedNCT03541694

Sanofi Pasteur, a Sanofi CompanyYellow Fever

Start: 2018-04-11End: 2018-05-30Updated: 2019-03-26